瓦雷尼克林会在吸烟的年轻人中促进戒断吗?
1School of Pharmacy and Medical Sciences, Griffith University, Southport, Australia.
Expert opinion on pharmacotherapy
|November 20, 2025
概括
瓦伦尼克林药物与咨询相结合,显著提高了青少年的vaping戒烟率. 然而,坚持的差异可能影响了结果,需要进一步研究长期有效性和安全性.
科学领域:
- 青少年健康 青少年健康
- 戒烟的方法 戒烟的方法
- 药理干预措施 药理干预
背景情况:
- 电子烟是美国学生中最常见的烟草产品.
- 电子烟往往是在使用可燃香烟,大麻和其他非法物质之前使用的.
- 需要有效的干预措施来支持年轻人戒烟.
研究的目的:
- 评估瓦雷尼克林在帮助青少年戒烟方面的疗效.
- 评估瓦雷尼克林在添加到行为咨询时的影响.
主要方法:
- 青少年中尼古丁吸烟停止的瓦伦尼克林 (ViVA) 试验涉及吸烟但不吸烟的青少年.
- 参与者接受了瓦雷尼克林加行为咨询或安慰剂与咨询.
主要成果:
- 与安慰剂相比,瓦伦尼克林显著提高了12周戒断率,从14%增加到51%.
- 瓦雷尼克林的疗效下降,戒断率在9-24周之间下降到28%.
- 在瓦雷尼克林组中,较高的药物坚持和咨询参与可能会影响结果.
结论:
- 瓦伦尼克林在与行为咨询相结合时,对青少年戒烟的初步承诺.
- 由于差异粘附的潜在偏差需要考虑.
- 进一步的长期研究是必不可少的,以确认瓦雷尼克林在青少年和成年人中持续有效性和安全性,用于戒烟.
关键词:
行为咨询 行为咨询临床试验临床试验临床试验临床试验临床试验吸烟 吸烟 吸烟 吸烟 吸烟 吸烟电子烟 (vaping) 是一种电子烟.瓦伦尼克林 (varenicline) 是一种药物.年轻人年轻人年轻人年轻人年轻人年轻人更多相关视频
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
26.3K
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
8.8K
相关概念视频
Stimulants
812
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
812
Drugs Acting on Autonomic Ganglia: Stimulants
2.0K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.0K
Substance Use Disorders Affecting Sleep
381
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
381
CNS Depressants: Alcohol and Nicotine
1.0K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.0K
Drug Dependence
1.6K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.6K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
655
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
655
